1. CSL and Cochlear say ‘show us the money’
Or at least show a bit of interest.
Here they have to chase government, whereas other countries, such as Singapore and Ireland:
- “actively come out and court companies like ours” with a unified package of incentives and benefits, he said. These could include a lower headline tax rate, and other financial concessions or benefits in exchange for specified investment, jobs and revenue outcomes from biotech and technology.